Eisai announced today that new study results on its in-house discovered and developed anticancer agent eribulin mesylate (HALAVEN®, "eribulin") will be presented during the 2022 San Antonio...

Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced that Robert E....

Cisco (NASDAQ: CSCO) will host its 2022 Virtual Annual Meeting of Stockholders on Thursday, December 8, 2022, beginning at 8:00 a.m. PST via audio webcast. Participants will include Cisco Chair...

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel products to treat brain health disorders, today...

Protagonist Therapeutics, Inc. (Nasdaq: PTGX) ("Protagonist" or "the Company") today announced that Dinesh V. Patel, Ph.D., President and Chief Executive Officer, will participate in a fireside...

Presentations include initial results for an investigational combination of fianlimab (LAG-3 inhibitor) and Libtayo (PD-1 inhibitor) in advanced non-small cell lung cancer TARRYTOWN, N.Y., Dec. 1,...

Life Time Group Holdings, Inc. ("Life Time" or the "Company") (NYSE: LTH) today announced that the Company is scheduled to participate in a fireside chat discussion at the 2022 Morgan Stanley...

JupiterOne supports AWS Marketplace Vendor Insights feature, AWS joins as member of JupiterOne Stellar Partner Program MORRISVILLE, N.C. and LAS VEGAS, Nov. 30, 2022 /PRNewswire/ -- AWS re:Invent...

Different results for two amyloid-clearing antibody drugs reinforce need to advance robust, diverse pipeline for Alzheimer's disease SAN FRANCISCO, Nov. 30, 2022 /PRNewswire/ -- The phase 3 trial...

CTA announces healthcare keynote, Nasdaq CEO and CoinDesk partnership ARLINGTON, Va., Nov. 30, 2022 /PRNewswire/ -- As anticipation builds for CES® 2023, the Consumer Technology Association...